Evidence map›Paper›PMID 36039035›Full record

ArticleEndocrinology, diabetes & metabolism2022

Lateralization in

Juhani Isojärvi, Marianna Viukari, Ilkka Pörsti, Helena Leijon, Tiina Vesterinen, Marko Seppänen, Pasi I Nevalainen, Niina Matikainen

Open access · goldAbstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Lateralization inEndocrinology, diabetes & metabolism · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Juhani IsojärviEndocrinology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Marianna ViukariEndocrinology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Ilkka PörstiFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Helena LeijonDepartment of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland.
Tiina VesterinenDepartment of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland.
Marko SeppänenTurku PET Centre, University of Turku, Turku, Finland.
Pasi I NevalainenDepartment of Internal Medicine, Tampere University Hospital, Tampere, Finland.
Niina MatikainenEndocrinology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID 0000-0003-0041-1240
University of Helsinki · FITampere University · FITampere University Hospital · FIUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSubtype classification method is essential when considering adrenalectomy as a possible treatment for primary aldosteronism. We aimed to retrospectively evaluate surgical outcomes of primary aldosteronism in patients who had undergone

methodsPostoperative clinical and biochemical cure and histopathological diagnosis from biobank samples were retrospectively evaluated in 44 patients who had all undergone preoperative

resultsAdrenalectomy side was based on

conclusionsOutcomes of adrenalectomy based on clinically significant lateralization in

Indexed as

AdrenalectomyHyperaldosteronismAdrenal GlandsEtomidateHumansPositron-Emission TomographyRetrospective StudiesEtomidatemetomidate11C-Metomidate positron emission tomographyadrenal venous samplingCYP11B2 immunostainingprimary aldosteronismsubtype classification in primary aldosteronismsurgical outcome

Identifiers

PMID36039035
PMCPMC9659653
OpenAlexW4293537952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.